Targeting the murine serotonin transporter: insights into human neurobiology

Nature Reviews. Neuroscience
Dennis L Murphy, Klaus-Peter Lesch

Abstract

Mutations resulting in reduced or completely abrogated serotonin-transporter (SERT) function in mice have led to the identification of more than 50 different phenotypic changes, ranging from increased anxiety and stress-related behaviours to gut dysfunction, bone weakness and late-onset obesity with metabolic syndrome. These multiple effects, which can be amplified by gene-environment and gene-gene interactions, are primarily attributable to altered intracellular and extracellular serotonin concentrations during development and adulthood. Much of the human data relating to altered expression of the gene that encodes SERT are based on genetic-association findings or correlations and are therefore not as robust as the experimental mouse results. Nevertheless, SERT-function-modifying gene variants in humans apparently produce many phenotypes that are similar to those that manifest themselves in mice.

References

Mar 1, 1983·Neuropharmacology·K FuxeP Eneroth
Feb 1, 1993·Journal of Neurobiology·M D GershonT P Rothman
Aug 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A LaaksoJ Hietala
Nov 1, 1996·Progress in Neurobiology·Z CohenE Hamel
Feb 1, 1997·Biological Reviews of the Cambridge Philosophical Society·W A Weiger
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·I SoraG R Uhl
Aug 7, 1998·Biological Psychiatry·I Lucki
Aug 26, 1999·Neuropharmacology·N M Barnes, T Sharp
Jun 7, 2000·The Journal of Clinical Investigation·S EddahibiS Adnot
Apr 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·I SoraG R Uhl
Dec 26, 2001·Brain Research Bulletin·D L MurphyG Uhl
Jan 16, 2002·Physiology & Behavior·J A BouwknechtB Olivier
May 1, 2002·Psychopharmacology·Andrew HolmesJacqueline N Crawley
Dec 5, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andrew HolmesJacqueline N Crawley
Jun 6, 2003·Molecular Microbiology·Milton H Saier
Jun 17, 2003·Journal of Neurochemistry·Sylvia MontañezLynette C Daws
Jun 20, 2003·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Sabah KelaïLaurence Lanfumey
Jul 19, 2003·Molecular Pharmacology·Fusun KilicGary Rudnick
Jul 29, 2003·Psychosomatic Medicine·Jeffrey F ScherrerWilliam R True
Sep 12, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andrew HolmesDennis L Murphy
Nov 18, 2003·Nature Reviews. Neuroscience·Patricia GasparLuc Maroteaux
Nov 19, 2003·The European Journal of Neuroscience·Saoussen BoualiJoëlle Adrien
Apr 17, 2004·Molecular Interventions·Dennis L MurphyKlaus-Peter Lesch
Apr 27, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Srijan SenDebashis Ghosh

❮ Previous
Next ❯

Citations

May 4, 2011·Archives of General Psychiatry·Randy D Blakely, Jeremy Veenstra-VanderWeele
Jun 17, 2008·Der Nervenarzt·T J RennerK-P Lesch
Dec 18, 2013·Pflügers Archiv : European journal of physiology·Gary RudnickFrancois Verrey
Mar 26, 2013·Cell and Tissue Research·Olivia F O'Leary, John F Cryan
Mar 13, 2009·Journal of Neural Transmission·Thomas WultschAndreas Reif
Mar 10, 2010·European Child & Adolescent Psychiatry·Susanne WalitzaKlaus W Lange
Jul 24, 2008·Journal of Autism and Developmental Disorders·Barbara L Thompson, Gregg D Stanwood
Jan 22, 2013·ACS Chemical Neuroscience·Nicole L Baganz, Randy D Blakely
May 20, 2009·The American Psychologist·Benjamin B Lahey
Jan 16, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mireille BasselinStanley I Rapoport
Oct 21, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gianluigi GuidottiMarco A Riva
Apr 12, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stefan M BergerDusan Bartsch
Sep 15, 2009·Nature Structural & Molecular Biology·Min LuDax Fu
Jan 1, 2011·Translational Psychiatry·O RiccioA G Dayer
Feb 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Brent J ThompsonRandy D Blakely
Jul 25, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Klaus-Peter LeschLise Gutknecht
Feb 27, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Dennis L MurphyKiara R Timpano
Dec 27, 2011·Cold Spring Harbor Perspectives in Biology·Randy D Blakely, Robert H Edwards
Nov 20, 2008·Genes, Brain, and Behavior·S S MoyJ M Lauder
Apr 18, 2009·Developmental Neuroscience·Aliya L Frederick, Gregg D Stanwood
Aug 21, 2010·Theoretical Biology & Medical Modelling·Janet BestMichael Reed
Nov 28, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Katherine C Krueger, Evan S Deneris
Sep 4, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jeremy Veenstra-VanderWeele, Zachary Warren
Oct 31, 2013·Calcified Tissue International·Sasha Dimitrova-NakovMichel Goldberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.